# Neurocrine Biosciences Inc: Form 8-K, filed Apr 4, 2025

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2025-04-04
- Accepted by EDGAR: Apr 4, 2025, 08:02 ET
- Period: 2025-04-02
- Accession: 0000914475-25-000081
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447525000081/nbix-20250402.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447525000081/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447525000081/nbix-20250402.htm

Filed Apr 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000914475-25-000081. Last ingested by Listed: Nov 11, 2026, 02:29 ET. No prices; not investment advice.